手法を比較

	QSAR	相同性モデリング（Homology Modeling）	ファーマコフォアモデリング
分野	バイオインフォマティクス	バイオインフォマティクス	バイオインフォマティクス
系統	Process / pipeline	Process / pipeline	Process / pipeline
提唱年	1964	1993	1977
提唱者	Corwin Hansch	Andrej Sali	Peter Gund
種類	Regression-based predictive modeling pipeline	Comparative structure prediction pipeline	Pattern-based virtual screening pipeline
原典	Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626.	Sali, A. & Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. Journal of Molecular Biology, 234(3), 779-815.	Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143.
別名	QSAR model, quantitative structure-activity relationship	comparative modeling, template-based modeling	pharmacophore pattern recognition, 3D pharmacophore
関連	3	4	3
概要	Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization.	Homology modeling, also called comparative modeling, predicts the three-dimensional structure of a protein using an experimentally-solved structure of a homologous protein as a template. Introduced by Sali and Blundell in 1993, this method exploits the principle that homologous proteins share similar spatial structures despite differing in amino acid sequence.	Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure.